Dr. Albert Bourla and COVID-19 Vaccine Impact

In the global fight against COVID-19, the Jewish people, who make up a tiny percentage of the world's population,

have had an outsized impact in the difficult battle to protect lives as scientists,

chief medical officers,

and top health care officials.

Yet the contributions of one extraordinary person tower above the rest.

That extraordinary person is Pfizer Chairman and CEO Dr. Albert Bourla.

Dr. Bourla led his team to deliver a COVID-19 vaccine in record time,

while taking a risk by declining US federal funding to avoid government bureaucracy and expedite vaccine production.

A child of Holocaust survivors from a Greek Jewish community destroyed by the Nazis,

he's proud of his Jewish heritage, is active in Holocaust remembrance and education,

and a strong supporter of Israel, which was the first country outside the U.S. to receive the Pfizer vaccine and the antiviral pill.

The pandemic is certainly not over, but the world is infinitely better off with Dr. Bourla helping lead the charge to save lives,

with more than two and a half billion Pfizer vaccine doses already distributed.

Because of Dr. Bourla's extraordinary contribution to humanity, as the world battles the worst health crisis in 100 years,

Dr. Albert Bourla has been selected as the recipient of the 2022 Genesis Prize,

the Jewish Nobel Prize.

Thank you and congratulations Dr. Bourla.